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Dengue viral antigens have been demonstrated in several types of naturally infected human tissues, but little
is known of whether these same tissues have detectable viral RNA. We studied tissue specimens from patients
with serologically or virologically confirmed dengue infections by immunohistochemistry (IHC) and in situ
hybridization (ISH), to localize viral antigen and RNA, respectively. IHC was performed on specimens obtained
from 5 autopsies and 24 biopsies and on 20 blood-clot samples. For ISH, antisense riboprobes to the dengue
E gene were applied to tissue specimens in which IHC was positive. Viral antigens were demonstrated in
Kupffer and sinusoidal endothelial cells of the liver; macrophages, multinucleated cells, and reactive lymphoid
cells in the spleen; macrophages and vascular endothelium in the lung; kidney tubules; and monocytes and
lymphocytes in blood-clot samples. Positive-strand viral RNA was detected in the same IHC-positive cells
found in the spleen and blood-clot samples. The strong, positive ISH signal in these cells indicated a high
copy number of viral RNA, suggesting replication.
Dengue infection is the most prevalent arthropod-
borne viral disease in subtropical and tropical regions
of the world [1]. The dengue virus (genus flavivirus,
family Flaviviridae) consists of a single positive-strand
RNA surrounded by an icosahedral nucleocapsid. There
are 4 distinct serotypes of dengue virus [2]. Infection
with 1 serotype provides lifelong protective immunity
to that serotype, but there is no cross-protective im-
munity between serotypes [3]. Infection with dengue
virus causes either a relatively mild disease, known as
classic dengue fever (DF), or a more severe form, den-
gue hemorrhagic fever (DHF), a fulminating illness that
is characterized by hemorrhagic manifestations and
plasma leakage and that can progress to dengue shock
syndrome (DSS) and death [4].
Studies of specimens obtained from patients with
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DHF/DSS using immunofluorescence and immuno-
histochemistry (IHC) revealed the presence of viral an-
tigens in many tissues, including liver, spleen, lymph
node, thymus, kidney, lung, and skin, but mainly in
mononuclear phagocytic cells [5–9]. The mere presence
of viral antigens within cells, especially phagocytic cells,
does not necessarily mean that the cells in question
support viral replication, since antigens may represent
phagocytized, killed virus or sequestered immune com-
plexes in the process of being degraded. Evidence from
in vitro studies suggested that other cells (e.g., hepa-
tocytes, B and T lymphocytes, endothelial cells, and
fibroblasts) could be potential targets for virus infection
and replication, but relatively little is known about the
involvement of these cells in in vivo infections [10–21].
The in situ hybridization (ISH) technique allows for
the precise localization of dengue viral RNA in infected
tissues. If the positive staining is intense, it could sug-
gest that viral replication may have occurred in these
tissues. Indeed, this technique has shown the presence
of viral RNA in the thymus and peripheral lymphocytes,
suggesting that these cells support in vivo viral repli-
cation [16]. However, these findings were based on only
a few cases and a limited range of tissue types and, thus,
need to be further investigated and confirmed. The
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purpose of the present study is to investigate the cellular lo-
calization of dengue virus in naturally infected human tissues
by applying both the IHC technique and the ISH technique to
tissue specimens obtained from patients with serologically or
virologically confirmed dengue infection. From previous vi-
rologic surveillance studies, dengue serotypes 1, 2, and 3 were
responsible for most outbreaks in Malaysia; therefore, the focus
was on these 3 serotypes. [22].
MATERIALS AND METHODS
Control Materials
Positive control tissue specimens. Dengue 1 (Hawaii), den-
gue 2 (New Guinea C), and dengue 3 (H87) viruses were ob-
tained from S. K. Lam (World Health Organization [WHO]
Collaborating Centre for Arbovirus Reference and Research,
Kuala Lumpur, Malaysia; Department of Medical Microbiology,
University of Malaya). One-day-old suckling mice were injected
intracerebrally with dengue 1 and 2. Sick mice were killed, and
the brains were harvested and fixed in 10% buffered formalin
for at least 48 h before routine processing and paraffin-em-
bedding. Since it was difficult to infect mice with dengue 3,
infected pig kidney cells (gift from Jane Cardosa, University of
Malaysia Sarawak, Sarawak) were used as a positive control
instead. Infected cells were harvested and resuspended in PBS
and, to improve cell adherence, were spotted onto slides coated
with 3-aminopropyltriethoxy-silane (Sigma). The slides were
air-dried, wrapped in aluminum foil, and stored at 80C.
Before use, the cells were fixed in either 4% paraformaldehyde
or acetone for 20 min at 4C.
Negative control tissue specimens. Negative controls com-
prised (1) uninfected suckling mouse brain, (2) suckling mouse
brain experimentally infected with Japanese encephalitis virus
(JEV), and (3) human brain or spinal cord naturally infected
with either measles, JEV, or enterovirus 71. These tissue spec-
imens were fixed in the same manner as were the positive
controls, except for the human tissue specimens, which were
fixed for 12 weeks.
Test Materials
All the cases in the present study were archived in the De-
partment of Pathology, University of Malaya, Malaysia. Tissue
specimens obtained from 5 autopsies and from 9 postmortem
and 15 antemortem biopsies and 20 peripheral blood-clot sam-
ples from patients clinically diagnosed—mainly as having DF,
DHF, or DSS—were examined (table 1). These patients were
included in the study because they were positive by either den-
gue IgM serologic testing, viral culture, or reverse-transcription
polymerase chain reaction (RT-PCR). In the case of antemor-
tem biopsies, they were done as part of the clinical investiga-
tions performed before the diagnosis of dengue infection. All
biopsies and autopsies were done after obtaining consent from
the patient or the next of kin. Blood-clot samples from sus-
pected cases of dengue infection were originally sent to the
Department of Medical Microbiology, University of Malaya, for
the purpose of dengue serologic testing.
Autopsy tissue specimens were fixed in 10% neutral buffered
formalin for 11 week, and biopsy specimens were fixed for at
least 24 h, before routine processing and embedding. After
serum separation by centrifugation, residual blood clots were
formalin-fixed for at least 2 days, routinely processed, and par-
affin-embedded as above. Four-micrometer-thick sections from
tissue blocks were placed on silanized slides and dewaxed for
30–60 min at 60C, followed by serial xylene and alcohol washes
before IHC and ISH.
IHC
Antidengue polyclonal antibodies (hyperimmune mouse ascitic
fluid) for 3 serotypes were obtained from R. E. Shope (WHO
Center for Tropical Diseases; University of Texas Medical Branch,
Galveston). These antibodies were tested for specificity and pos-
sible cross-reactivity between dengue strains and other unrelated
viruses, and IHC conditions were optimized before use.
The entire IHC procedure was performed at room temper-
ature, except where stated otherwise. Deparaffinized tissue sec-
tions were washed in running water for 10 min and digested
with 100 mg/mL proteinase K (Promega) in a buffer (0.01 mol/
L Tris-HCl [pH 7.8], 0.005 mol/L EDTA, and 0.5% SDS) for
15 min. After a second wash with water, the sequential incu-
bations were (1) 3% H2O2 in absolute methanol for 20 min;
(2) normal rabbit serum (Gibco BRL) diluted 1:20 in Tris-
buffered saline (TBS), for 20 min; (3) primary antibody (diluted
1:500 in TBS), overnight at 4C; (4) biotinylated rabbit anti–
mouse antibody (diluted 1:300; Dako); (5) avidin biotin–horse-
radish peroxidase complex (Dako) and 3,3′ diaminobenzidene
tetrahydrochloride (Sigma), according to the manufacturers’ pro-
tocols. Between steps, the slides were washed in TBS for 5 min.
Finally, the slides were washed in running water, counterstained
in Harris hematoxylin, dehydrated, and mounted with DPX
(Sigma). In addition to the negative controls, an adsorption con-
trol in which IHC was performed using dengue antibody after
absorption with excess dengue virus antigens and a “minus pri-
mary antibody” control was also included in the experiments.
Riboprobe Preparation
Dengue viral RNA was extracted from dengue 1–, 2–, and 3–
infected C6/36 cells by use of TRIzol reagent (Gibco BRL), and
respective cDNAs were produced by use of published specific
primers to the E gene and the Access RT-PCR Kit (Promega)
[23]. RT-PCR was performed in a thermocycler (DNA engine
 at U
niversiti M
alaya on February 10, 2012
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
Dengue Virus Localization in Infected Human Tissues • JID 2004:189 (15 April) • 1413
Table 1. Clinical diagnosis, laboratory findings, and tissue specimens examined in patients with dengue
infection.
Type of specimen,
case number Clinical diagnosis Laboratory results
Tissue speci-
men(s) examined
Autopsy
1 DSS IgM positive Multiple organs
2 Acute hemorrhagic pancreatitis IgM negative, culture negative, RT-PCR
positive for dengue 2 in serum
Multiple organs
3 DHF IgM negative, dengue 1 isolated Multiple organs
4 DSS and pulmonary hemorrhage IgM positive Multiple organs
5 DSS and diabetes mellitus IgM positive Multiple organs
Postmortem biopsy
6 DHF IgM positive Liver
7 DHF IgM positive Liver
8 DHF IgM positive Liver, kidney, heart
9 DSS IgM negative, dengue 3 isolated Liver
10 DHF IgM positive Liver, lung
11 DSS IgM positive Liver, kidney
12 DHF IgM positive Liver
13 DSS IgM negative, dengue 3 isolated Liver
14 DSS and pulmonary hemorrhage IgM positive Liver, kidney, lung
Antemortem biopsy
15 DSS IgM positive Liver
16 DF IgM positive Liver
17 DF IgM positive Liver
18 DHF IgM positive Liver
19 DHF IgM positive Liver
20 DHF with acute hepatitis IgM positive Liver
21 DF IgM positive Bone marrow
22 DF IgM positive Bone marrow
23 DHF IgM positive Bone marrow
24 DF IgM positive Bone marrow
25 DHF IgM positive Bone marrow
26 DF IgM positive Bone marrow
27 DF IgM positive Bone marrow
28 DF IgM positive Bone marrow
29 DF IgM positive Bone marrow
Peripheral blood
30–49 All DF All IgM positive All blood clots
NOTE. DF, dengue fever; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; RT-PCR, reverse-transcriptionpolymerase
chain reaction.
PTC-200 Peltier; MJ Research), and the conditions were the
following: (1) 45 min at 48C then 1 min at 94C; (2) 1 min
at 94C, 1 min at 58C, and 2 min at 72C, for 40 cycles; and
(3) 5 min at 72C.
The ∼260-bp PCR fragments were purified by use of the High
Pure PCR Purification Kit (Boehringer Mannheim), cloned into
a suitable vector (pGEMT-Easy; Promega), and transformed into
competent Escherichia coli cells (JM109; Promega). White and
pale blue colonies were identified on X-Gal minimal agar plates
and screened for the presence and orientation of the inserts by
EcoRI restriction endonuclease digestion and by use of PCR using
T7 and dengue-specific primers. Plasmids with inserts in 2 ori-
entations were isolated by use of a modified alkaline lysis method
[24]. After linearization with SpeI restriction endonuclease (Pro-
mega), antisense and sense riboprobes were generated by use of
the DIG RNA Labeling Kit SP6/T7 (Boehringer Mannheim).
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Table 2. Naturally-infected human tissue specimens and cells positive for dengue virus by immunohistochemistry and in situ
hybridization.
Tissue/organ
No. of cases Positive cells
Case
number(s)aTested
IHC
positive
ISH
positive IHC ISH
Liver 20 3 0 Kupffer cell, endothelium, lymphocytes and monocytes
in lumen of blood vessels
Nil 3, 10, 11
Spleen 5 3 2 Macrophages, binucleated and multinucleated giant cells;
lymphoid, centroblastic-like, immunoblast-like cells
Macrophages, binucleated cells; reactive lym-
phoid, centroblast-like, immunoblast-like cells
1, 3, 4
Kidney 8 3 0 Tubules Nil 3, 4, 11
Lung 6 1 0 Alveolar macrophages, endothelium, monocytes in lumen
of blood vessels
Nil 4
Bone marrow 9 1 0 Myeloid cells Nil 25
Blood clot 20 8 7 Monocytes, lymphocytes Monocytes, lymphocytes 36–43
NOTE. IHC, immunohistochemistry; ISH, in situ hybridization; Nil, no positive-staining cells.
a As in table 1.
Digoxigenin (DIG)–labeled riboprobes were purified as above
and stored at 80C until use.
ISH
We used the ISH method described by Killen et al. [16]. The
sensitivity and specificity of the riboprobes were tested and
optimized by varying pretreatment with proteinase K, before
ISH was performed on all IHC-positive, and some IHC-neg-
ative, tissue specimens.
In brief, deparaffinized tissue sections were pretreated with
HCl and proteinase K (100 mg/mL; 15 min; 37C). The hybrid-
ization and posthybridization steps were performed as described
elsewhere [16]. Approximately 0.5–1.0 ng of either antisense or
sense riboprobes (used as a mixture of 3 serotype-specific probes
or as single probes) was pipetted onto tissue sections, covered
with diethylpyrocarbonate-treated coverslips, and incubated for
16–20 h at 45C. Probes that had hybridized with viral RNA
were detected by use of an anti-DIG antibody conjugated to
alkaline phosphatase and nitroblue tetrazolium/5-bromo-4-
chloro-indol-3-indolyl phosphate color substrate (Boehringer
Mannheim). The slides were counterstained with Mayer’s he-
matoxylin and aqueous-mounted with glycergel (Dako).
RESULTS
Antibody specificity and sensitivity. Dengue antibodies to
all 3 serotypes cross-reacted with each other. Dengue 1 antibody
showed the strongest staining on positive controls and thus was
used for all subsequent IHC assays. Specificity testing of this
antibody against JEV, enterovirus 71, and measles virus–in-
fected tissue specimens convincingly showed it to be nonreac-
tive for these viruses. All the other negative controls were also
found to be negative.
IHC findings. Dengue viral antigens were detected in the
liver, spleen, lung, kidney, and peripheral blood leukocytes
(PBLs) (table 2). Other tissue specimens, including thymus,
lymph node, thyroid, pancreas, heart, adrenal gland, skeletal
muscle, intestine, and brain, were found to be negative. Mega-
karyocytes in the bone marrow were consistently found to be
negative for viral antigens.
In general, antigens were immunolocalized to the cytoplasm,
with no nuclear staining whatsoever. In the liver, fine granular
deposits of dengue viral antigens were localized predominantly
within Kupffer cells, endothelium (figure 1A), and peripheral
monocytes in vascular lumen. In the spleen, viral antigens were
clearly observed in the cytoplasm of macrophages, binucleated
cells (figure 1E), multinucleated giant cells, and reactive lym-
phoid cells in the red pulp. In the white pulp, lymphoid cells,
and some centroblast-like and immunoblast-like cells (figure
1G) in the germinal centers of lymphoid follicles were found
to be IHC positive. In the kidney, viral antigens were detected
as discrete granular deposits within the lining cells of the tu-
bules. Viral antigens were detected in alveolar macrophages
(figure 1B), pulmonary vascular endothelium, and monocytes
inside blood vessels in the lung (figure 1C).
The majority of PBLs found to be positive for viral antigens
were monocytes (figure 1I), although some lymphocytes were
also found to be positive. Seven of the 8 positive blood samples
were collected between days 4 and 8 of fever, and 1 was collected
at day 15 of fever.
Riboprobe specificity and sensitivity. DIG-labeled anti-
sense riboprobes used in optimized ISH assays could detect
dengue viral RNA in positive control tissue specimens, giving
clear signals with little background staining. Respective ribo-
probes were also serotype specific. Moreover, specificity tests
showed that there was no evidence of cross-hybridization with
JEV, enterovirus 71, or measles RNA. Uninfected tissue and
blood samples showed negative staining.
ISH findings. In the splenic red pulp, viral RNA was lo-
calized to the cytoplasm of macrophages, reactive lymphoid,
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Figure 1. A, Dengue viral antigens detected in the liver in Kupffer and endothelial cells (arrow), but not in hepatocytes. Inset, A Kuppfer cell
(short arrow) and an endothelial cell (long arrow). Shown are dengue viral antigens in the lung in alveolar macrophages (B, arrows), vascular lumen
monocyte (C, short arrow), and vascular endothelium (C, long arrow). D, Dengue viral RNA localized in macrophages and reactive lymphoid cells in
the red pulp and white pulp of the spleen. Shown are dengue viral antigens and RNA in the binucleated cells (E, long arrow, and F, arrow, respectively)
in the red pulp, and viral antigens in a macrophage (E, short arrow, and G, short arrow). G, Viral antigens localized to an immunoblast-like cell
(arrow). H, Dengue viral RNA in a centroblast-like cell (short arrow) and immunoblast-like cell (long arrow) in the germinal centers. I, Dengue viral
antigens in a peripheral blood monocyte (arrow). J, Viral RNA in a peripheral monocyte (long arrow) and a lymphocyte (short arrow). A–C, E, G, and
I, Immunohistochemistry, hematoxylin counterstain; D, F, H, and J, In situ hybridization, hematoxylin counterstain. Magnification, 100 (A and D) and
500 (B, C, and E–J).
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binucleated cells (figure 1F), and multinucleated giant cells (ta-
ble 2). In the white pulp, viral RNA was detected in centroblast-
like and immunoblast-like cells (figure 1D and 1H) found in
germinal centers. On occasion, there were also ISH-positive
mononuclear cells in the lumen of splenic blood vessels. In the
blood-clot samples, viral RNA was mainly localized to the cy-
toplasm of monocytes and some lymphocytes (figure 1J).
Repeat ISH using single serotype probes on the positive
spleens showed evidence of dengue 1 in 1 case and dengue 3
in the other. For the blood-clot samples, 6 showed dengue 3
infection, and 1 showed dengue 1 infection. ISH using sense
riboprobes did not detect any negative-strand RNA of repli-
cative intermediates (RIs), in both test and positive controls.
Liver Kupffer cells, lung alveolar macrophages, kidney tubules,
and endothelium in these organs were found to be negative for
viral RNA.
DISCUSSION
Dengue viral antigens have been detected in various human tis-
sues in previous studies, but it is not certain whether viral RNA
can be localized to these same tissues, since little work has been
done to establish this [5–9]. In fact, there are only 2 other pub-
lished studies that have attempted to detect dengue viral RNA
in a small number of naturally infected human tissues [16, 25].
The demonstration of positive-strand viral RNA by ISH, in
reactive B lymphoid cells in the germinal centers of the spleen—
including centroblasts and immunoblasts—and peripheral lym-
phocytes has not been reported previously. The mere presence
of viral RNA does not necessarily imply that active intracellular
viral replication has occurred. Nonetheless, a strong signal, in-
dicating a high copy number, is probably good supportive ev-
idence for infection and viral replication, particularly in cells
that are not known to be phagocytic. This finding is supported
by in vitro studies, which have demonstrated dengue virus
replication in human B lymphoblastoid cells [11].
Unfortunately, in the present study, sense riboprobes, which
theoretically should hybridize with RIs, were apparently neg-
ative on the same cells that were positive with antisense ri-
boprobes. We are uncertain why this was so. Demonstration
of RIs would have confirmed viral replication [16]. In recent
studies using sensitive quantitative RT-PCR–based methods,
RIs could be detected in cell cultures, as well as PBLs of patients
with dengue infection, but the copy numbers were generally
very low [26, 27]. In PBLs, for example, copy numbers ranged
from only 40 to 11,000 copies/106 cells [27]. Furthermore, elec-
tron microscopic ISH studies of dengue 2–infected mosquito
cells showed no hybridization signal, by use of the sense, single-
stranded DNA probe, but showed a positive signal, by use of
the antisense probe [28]. There is also the possibility that what-
ever RIs that were present in the tissue specimens could have
been destroyed as a result of formalin-fixation and tissue pro-
cessing. All these possibilities could explain the apparent ab-
sence of RIs in the tissue specimens we tested, despite the strong
positivity for positive-strand viral RNA. It may be possible to
detect RIs using in situ PCR in formalin-fixed tissue specimens.
The peripheral blood lymphocytes found to be positive for
viral antigen and RNA in the present study could represent either
B or T cells. Dengue virus has been isolated from, and viral
antigen has been demonstrated in, circulating B lymphocytes in
both primary and secondary infections [29]. Furthermore, in
vitro replication of dengue virus in mitogen-stimulated and
-unstimulated human peripheral blood B lymphocytes has been
reported elsewhere [11, 12]. Human primary B lymphocytes
infected in vitro have recently been shown to produce inter-
leukin-6 and tumor necrosis factor–a, suggesting that B lym-
phocytes may play an important role in dengue pathogenesis
[12]. The permissiveness of T lymphocytes to dengue virus has
been demonstrated in in vitro infections but not in in vivo
infections [13, 14].
In our study, we have demonstrated for the first time the
cellular localization of dengue viral RNA in splenic macrophages
and peripheral blood monocytes. Again, the strong staining ob-
tained suggested that viral replication may have occurred in these
cells. Dengue RNA has been demonstrated before in macrophages
in the lymph node and skin by use of an in situ PCR method
[25]. In in vitro experiments, human peripheral blood monocytes
were found to support viral replication [14, 30–32].
In contrast, the failure to detect viral RNA in antigen-positive
Kupffer cells and alveolar macrophages suggests viral phago-
cytosis or immune complex sequestration rather than viral rep-
lication. Interestingly, in vitro dengue virus infection of human
Kupffer cells showed that these cells were not involved in pro-
ductive infection [33]. It is possible that, in vivo, Kupffer cells
and alveolar macrophages do not support viral replication but
may play a protective role against dengue virus by their phago-
cytic function. In the present study, the detection of viral an-
tigens (with or without viral RNA) in cells of the mononuclear
phagocytic system confirmed previous findings [5–9]. This sup-
ports the theory that monocytes and macrophages play a sig-
nificant role in the pathogenesis of DHF/DSS, in view of their
possible role in the infection-enhancement phenomenon, es-
pecially in secondary infection [34, 35]. It has been postulated
that infected monocytes/macrophages and activated T lym-
phocytes release mediators, which act directly on the vascular
endothelium to increase vascular permeability, resulting in
plasma leakage, shock, and death [36–40].
Direct vascular endothelium infection may also contribute
to DSS. Several in vitro studies have shown that viral replication
occurs in endothelial cell cultures [15–20]. However, the pres-
ent study has found no evidence of viral RNA in the endo-
thelium of the organs studied, although viral antigens were
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demonstrated in vascular endothelium in the lung and liver.
Viral antigens have also been observed in vascular endothelium
in the liver and, apparently, also in the brain [6, 7]. However,
viral RNA or endothelial damage apparently has not been ob-
served in natural human infections [36, 41]. The process of
pinocytosis could explain the detection of viral antigens in vas-
cular endothelium, since an ultrastructurally increased number
of vacuoles and pinocytotic vesicles was observed in the endo-
thelium of skin biopsy specimens from patients with DHF [41].
The absence of viral RNA in kidney tubular cells that im-
munolocalize for viral antigen suggests that viral replication did
not occur in these cells. These antigens could represent reab-
sorbed immune complexes after elimination through the kid-
ney, analogous to that in yellow fever, in which tubular cells
also demonstrated the presence of yellow fever viral antigen
[42]. In separate studies, viral antigens [5] and viral RNA have
been demonstrated in hepatocytes by an in situ PCR method
[25]. No viral antigens or RNA were detected in hepatocytes
from our cases. The reasons for this may be that viral antigens
seem to appear early in hepatocytes after infection, and pro-
duction of infectious particles is rather low [43]. It is interesting
that there seems to be no evidence for the involvement of
megakaryocytes found in the bone marrow. This suggests that
thrombocytopenia, a characteristic of DHF/DSS, may not be
associated with failure of platelet production. There appears to
be no relationship between detection of dengue virus and the
severity of clinical disease (table 2). Nonetheless, more cases
have to be studied to confirm this.
In conclusion, macrophages, peripheral blood monocytes,
reactive splenic lymphoid cells, and peripheral lymphocytes
may be the major target cells of dengue viral replication in
natural human infections. These findings have to be confirmed
by examining tissue specimens from more cases of human in-
fection. Electron microscopy and in situ PCR could be useful
tools to confirm viral replication.
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